Pulse Seismic Inc. (TSX:PSD)
Canada · Delayed Price · Currency is CAD 3.970
+0.060 (1.53%)
Aug 1, 2025, 4:00 PM EDT
CTI BioPharma Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Operating Revenue | 49.38 | 23.38 | 39.13 | 9.35 | 48.72 | 11.01 | Upgrade |
Other Revenue | - | - | - | 0.23 | 0.43 | 0.34 | Upgrade |
| 49.38 | 23.38 | 39.13 | 9.57 | 49.15 | 11.35 | Upgrade | |
Revenue Growth (YoY) | 33.30% | -40.25% | 308.85% | -80.53% | 333.08% | -53.02% | Upgrade |
Gross Profit | 49.38 | 23.38 | 39.13 | 9.57 | 49.15 | 11.35 | Upgrade |
Selling, General & Admin | 9.24 | 7.88 | 8.7 | 6.72 | 6.75 | 3.96 | Upgrade |
Operating Expenses | 18.32 | 17.06 | 17.88 | 16.8 | 17.37 | 15.98 | Upgrade |
Operating Income | 31.05 | 6.32 | 21.25 | -7.23 | 31.78 | -4.63 | Upgrade |
Interest Expense | -0 | -0.02 | -0.06 | -0.09 | -1.77 | -2.02 | Upgrade |
Interest & Investment Income | 0.4 | 0.47 | 0.55 | 0.1 | 0.06 | 0.21 | Upgrade |
Other Non Operating Income (Expenses) | -0.01 | -0.01 | -0.11 | -0.11 | -0.12 | -0.18 | Upgrade |
EBT Excluding Unusual Items | 31.43 | 6.76 | 21.63 | -7.32 | 29.95 | -6.62 | Upgrade |
Merger & Restructuring Charges | - | - | - | -0.81 | -0.09 | - | Upgrade |
Other Unusual Items | - | - | - | - | 0.32 | - | Upgrade |
Pretax Income | 31.43 | 6.76 | 21.63 | -8.14 | 30.18 | -6.62 | Upgrade |
Income Tax Expense | 9.12 | 3.37 | 6.62 | -0.23 | 8.67 | 0.17 | Upgrade |
Net Income | 22.31 | 3.39 | 15.01 | -7.91 | 21.51 | -6.79 | Upgrade |
Net Income to Common | 22.31 | 3.39 | 15.01 | -7.91 | 21.51 | -6.79 | Upgrade |
Net Income Growth | 75.36% | -77.40% | - | - | - | - | Upgrade |
Shares Outstanding (Basic) | 51 | 51 | 53 | 54 | 54 | 54 | Upgrade |
Shares Outstanding (Diluted) | 51 | 51 | 53 | 54 | 54 | 54 | Upgrade |
Shares Change (YoY) | -2.91% | -3.36% | -0.87% | -0.17% | -0.00% | - | Upgrade |
EPS (Basic) | 0.44 | 0.07 | 0.28 | -0.15 | 0.40 | -0.13 | Upgrade |
EPS (Diluted) | 0.44 | 0.07 | 0.28 | -0.15 | 0.40 | -0.13 | Upgrade |
EPS Growth | 80.61% | -76.62% | - | - | - | - | Upgrade |
Free Cash Flow | 34.34 | 14.15 | 23.5 | 11.98 | 29.79 | 3.81 | Upgrade |
Free Cash Flow Per Share | 0.68 | 0.28 | 0.44 | 0.22 | 0.55 | 0.07 | Upgrade |
Dividend Per Share | 0.063 | 0.059 | 0.054 | 0.050 | 0.013 | - | Upgrade |
Dividend Growth | 11.11% | 9.30% | 7.50% | 300.00% | - | - | Upgrade |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | Upgrade |
Operating Margin | 62.89% | 27.03% | 54.31% | -75.52% | 64.66% | -40.79% | Upgrade |
Profit Margin | 45.18% | 14.50% | 38.35% | -82.62% | 43.77% | -59.79% | Upgrade |
Free Cash Flow Margin | 69.54% | 60.52% | 60.05% | 125.18% | 60.61% | 33.55% | Upgrade |
EBITDA | 40.04 | 15.43 | 30.36 | 2.64 | 41.9 | 6.89 | Upgrade |
EBITDA Margin | 81.08% | 66.00% | 77.60% | 27.57% | 85.25% | 60.70% | Upgrade |
D&A For EBITDA | 8.98 | 9.11 | 9.12 | 9.87 | 10.12 | 11.52 | Upgrade |
EBIT | 31.05 | 6.32 | 21.25 | -7.23 | 31.78 | -4.63 | Upgrade |
EBIT Margin | 62.89% | 27.03% | 54.31% | -75.52% | 64.66% | -40.79% | Upgrade |
Effective Tax Rate | 29.02% | 49.84% | 30.62% | - | 28.72% | - | Upgrade |
Revenue as Reported | - | - | - | 9.57 | 49.15 | 11.35 | Upgrade |
Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.